According to the Endocrine Society guidelines, which finding in a patient with subclinical hypothyroidism (TSH 6.5 mIU/L, free T4 normal) is the STRONGEST indication to initiate levothyroxine therapy?
- A Positive anti-TPO antibodies with TSH >10 mIU/L ✓
- B Age >65 years
- C TSH between 4.5 and 10 mIU/L without symptoms
- D Presence of goiter on examination
Correct answer: A. Positive anti-TPO antibodies with TSH >10 mIU/L
Explanation
Current guidelines recommend levothyroxine therapy for subclinical hypothyroidism when TSH >10 mIU/L (high risk of progression) or when TSH is 4.5–10 mIU/L with positive anti-TPO antibodies (indicating autoimmune thyroiditis with high conversion risk) or when the patient is symptomatic. Age >65 is a reason for caution rather than initiation due to risk of AF and osteoporosis with overtreatment. Goiter alone without antibodies or high TSH is not a definitive trigger.
Reference: Harrison's Principles of Internal Medicine, 21st ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.